EMCDDA–Europol 2017 Annual Report on the implementation of Council Decision 2005/387/JHA


This report presents the key activities performed by the EMCDDA and Europol in 2017 and the results of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances, including new psychoactive substances notified in 2017, Joint Reports produced, risk assessments conducted and public health-related alerts and advisories issued to the EU Early Warning System Network.

Download as PDF

Table of contents

  • Background to this report
  • Overview
  • Implementation arrangements and cooperation with the European Union Pharmacovigilance system
    • Specific implementation arrangements
      • Assistance to national early warning systems
      • Annual meeting of the EU Early Warning System Network
      • Strengthening early warning and response
      • Links with forensic science and toxicology networks
      • Supporting activities and cooperation with third countries
      • Cooperation with international organisations
      • Europol
    • Cooperation with the European Medicines Agency and the pharmacovigilance system
    • New legislation
    • Cooperation with ECHA, EFSA and ECDC
  • Core activities
    • Early warning activities (Article 4)
      • New psychoactive substances detected and formally notified in 2017
      • Reporting tools and 2016 seizure data
    • Public health-related alerts
    • EMCDDA–Europol Joint Reports (Article 5)
    • Risk assessments (Article 6)
  • Conclusions
  • Publications
  • Annex 1. New psychoactive substances notified for the first time in 2017 under the terms of Council Decision 2005/387/JHA
  • Annex 2. List of risk communications issued to the EU Early Warning System Network in 2017 under the terms of Council Decision 2005/387/JHA